About Pivot Bio
Pivot Bio is a company based in Berkeley (United States) founded in 2010 by Alvin Tamsir and Karsten Temme. Pivot Bio has raised $618.08 million across 7 funding rounds from investors including Monsanto, Bunge and Rockefeller Capital Management. Pivot Bio offers products and services including PROVEN® 40, RETURN®, and N-OVATOR Program. Pivot Bio operates in a competitive market with competitors including Amyris, Inscripta, Ginkgo Bioworks, Syngenta and Asimov, among others.
- Headquarter Berkeley, United States
- Founders Alvin Tamsir, Karsten Temme
- Stage Unicorn
-
Sectors
HealthcareAgriculture Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$618.08 M (USD)
in 7 rounds
-
Latest Funding Round
$430 M (USD), Series D
Jul 19, 2021
-
Investors
Monsanto
& 17 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pivot Bio
Pivot Bio offers a comprehensive portfolio of products and services, including PROVEN® 40, RETURN®, and N-OVATOR Program.
Delivers steady nutrition for corn crops to enhance yield.
Boosts nutrition for wheat and small grains productivity.
Rewards farmers for using microbial nitrogen to cut emissions.
People of Pivot Bio
Unlock access to complete
Unlock access to complete
Software Development Team
21 people
Leadership Team
20 people
Scientific Team
10 people
Product Management Team
10 people
Sales and Marketing
7 people
Data Analysis and Operations Team
6 people
Operations Team
6 people
Finance and Accounting
3 people
Unlock access to complete
Funding Insights of Pivot Bio
Pivot Bio has successfully raised a total of $618.08M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $430 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pivot Bio
Pivot Bio has secured backing from 18 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Monsanto, Bunge and Rockefeller Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
Private equity firm focused on sustainable investments
|
Locked | Locked | Locked |
Investor details for Pivot Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pivot Bio
Investment portfolio details for Pivot Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pivot Bio
Detailed financials for Pivot Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pivot Bio Comparisons
Peer comparison for Pivot Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pivot Bio
Pivot Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Ginkgo Bioworks, Syngenta and Asimov, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
Detailed competitors of Pivot Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pivot Bio
Complete news archive for Pivot Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pivot Bio
Pivot Bio was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Pivot Bio is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Chris Abbott is the current CEO of Pivot Bio.
Pivot Bio is a funded company, having raised a total of $618.08M across 7 funding rounds to date.
Pivot Bio was founded in 2010 and is headquartered in Berkeley, United States. Microbe-based products for crop nutrition are developed within the agricultural biotechnology sector. Nitrogen-fixing microorganisms are engineered to establish symbiotic relationships with corn plants, converting atmospheric nitrogen into usable forms directly at the roots through biological processes. Application occurs via an in-furrow method, with consistent performance across varying topography, weather conditions, and soil types.
Pivot Bio offers PROVEN® 40, RETURN®, and N-OVATOR Program.
Pivot Bio has 18 investors. Key investors include Monsanto, Bunge, Rockefeller Capital Management, Temasek, and DCVC.
The valuation of Pivot Bio is $2B as of Jul 2021.